Cilostazol Tablet
Product Images NDC 60505-2522

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cilostazol (NDC 60505-2522). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1.jpg (Figure1)

A line graph showing plasma concentration (ng/mL) over time (hours) for cilostazol and its metabolites 3,4-dehydrocilostazol and 4'-trans-hydroxycilostazol. The graph tracks concentration changes from 0 to 24 hours post-dose, with cilostazol having the highest plasma levels followed by the two metabolites.*

FDA Label Image

Figure2.jpg (Figure2)

A bar graph comparing percent mean improvement in maximal walking distance for placebo, cilostazol 50 mg b.i.d., and cilostazol 100 mg b.i.d. groups across eight trials with varying durations from 12 to 24 weeks, showing higher improvements generally with the 100 mg dose.*

FDA Label Image

Structure.jpg (Structure)

Chemical structure diagram of cilostazol, showing its molecular connectivity including a triazole ring, cyclohexane ring, aromatic ring, and side chains as part of its active ingredient structure.*

FDA Label Image

Cilo-imtb-100mg-lbl-60 (Cilo Imtb 100mg Lbl 60)

Label for Cilostazol Tablets, USP 100 mg oral tablets by Apotex Corp. The label includes storage instructions, dosage form, tablet count of 60, the NDC 60505-2522-1, and manufacturer/distributor information. It also notes the product is prescription only and includes a barcode.*

FDA Label Image

Cilo-imtb-50mg-lbl-60 (Cilo Imtb 50mg Lbl 60)

Packaging label for Cilostazol Tablets USP, 50 mg, containing 60 oral tablets. Manufactured and labeled by Apotex Corp., the label shows storage instructions and dispensing information, including the NDC 60505-2521-1 and directions to dispense the enclosed Patient Information Leaflet.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.